European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's request

  • 📰 AP
  • ⏱ Reading Time:
  • 20 sec. here
  • 12 min. at publisher
  • 📊 Quality Score:
  • News: 46%
  • Publisher: 51%

Astrazeneca PLC أخبار

Medication,Immunizations,General News

The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn at the company's request.

FILE - Medical staff prepares an AstraZeneca coronavirus vaccine during preparations at the vaccine center in Ebersberg near Munich, Germany, Monday, March 22, 2021. The pharma giant AstraZeneca has requested that its European authorization for its COVID vaccine be pulled, according to the EU medicines regulator on Wednesday, May 8, 2024.

The U.K.'s national coronavirus immunization program in 2021 heavily relied on AstraZeneca’s vaccine, which was largely developed by scientists at Oxford University with significant financial government support. But even Britain later resorted to buying the mRNA vaccines for its COVID booster vaccination programs and the AstraZeneca vaccine is now rarely used globally.

 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.
لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 728. in SA

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين